Xing Wei, Hui Li, Shijing Wu, Tian Zhu, Ruifang Sui
{"title":"Genetic analysis and clinical features of three Chinese patients with Oguchi disease.","authors":"Xing Wei, Hui Li, Shijing Wu, Tian Zhu, Ruifang Sui","doi":"10.1007/s10633-022-09910-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Oguchi disease is a rare autosomal recessive form of congenital stationary night blindness caused by disease-causing variants in the rhodopsin kinase gene (GRK1) or the arrestin gene (SAG). Our study aims to describe the clinical features and identify the genetic defects for three Chinese patients with Oguchi disease.</p><p><strong>Methods: </strong>We conducted detailed ophthalmologic examinations for three patients from three unrelated non-consanguineous Chinese families. Targeted next-generation sequencing (targeted NGS) and copy number variations (CNVs) analysis were applied to screen pathogenic variants. Sanger sequencing validation, quantitative real-time PCR (qPCR), and segregation analysis were further performed for confirmation. Subsequently, a combined genetic and structural biology approach was used to infer the likely functional consequences of novel variants.</p><p><strong>Results: </strong>All three patients presented with typical clinical features of Oguchi disease, including night blindness, characteristic fundus appearance (Mizuo-Nakamura phenomenon), attenuated rod responses, and negative ERG waveforms. Their visual acuity and visual field were normal. Genetic analysis revealed two pathogenic variants in SAG and four pathogenic variants in GRK1. Patient 1 was identified to harbor compound heterozygous SAG variants c.874C > T (p.R292*) and exon2 deletion. Compound heterozygous GRK1 variants c.55C > T (p.R19*) and c.1412delC (p.P471Lfs*52) were found in patient 2. In patient 3, compound heterozygous GRK1 variants c.946C > A (p.R316S) and c.1388 T > C (p. L463P) were detected.</p><p><strong>Conclusions: </strong>We reported the first two Chinese Oguchi patients with novel GRK1 pathogenic variants (P471Lfs*52, R316S, L463P) and one Oguchi case with SAG, indicating both GRK1 and SAG are important causative genes in Chinese Oguchi patients.</p>","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":"146 1","pages":"17-32"},"PeriodicalIF":2.6000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Documenta Ophthalmologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10633-022-09910-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Oguchi disease is a rare autosomal recessive form of congenital stationary night blindness caused by disease-causing variants in the rhodopsin kinase gene (GRK1) or the arrestin gene (SAG). Our study aims to describe the clinical features and identify the genetic defects for three Chinese patients with Oguchi disease.
Methods: We conducted detailed ophthalmologic examinations for three patients from three unrelated non-consanguineous Chinese families. Targeted next-generation sequencing (targeted NGS) and copy number variations (CNVs) analysis were applied to screen pathogenic variants. Sanger sequencing validation, quantitative real-time PCR (qPCR), and segregation analysis were further performed for confirmation. Subsequently, a combined genetic and structural biology approach was used to infer the likely functional consequences of novel variants.
Results: All three patients presented with typical clinical features of Oguchi disease, including night blindness, characteristic fundus appearance (Mizuo-Nakamura phenomenon), attenuated rod responses, and negative ERG waveforms. Their visual acuity and visual field were normal. Genetic analysis revealed two pathogenic variants in SAG and four pathogenic variants in GRK1. Patient 1 was identified to harbor compound heterozygous SAG variants c.874C > T (p.R292*) and exon2 deletion. Compound heterozygous GRK1 variants c.55C > T (p.R19*) and c.1412delC (p.P471Lfs*52) were found in patient 2. In patient 3, compound heterozygous GRK1 variants c.946C > A (p.R316S) and c.1388 T > C (p. L463P) were detected.
Conclusions: We reported the first two Chinese Oguchi patients with novel GRK1 pathogenic variants (P471Lfs*52, R316S, L463P) and one Oguchi case with SAG, indicating both GRK1 and SAG are important causative genes in Chinese Oguchi patients.
背景:Oguchi病是一种罕见的常染色体隐性先天性静止性夜盲症,由视紫红质激酶基因(GRK1)或抑制蛋白基因(SAG)的致病变异引起。本研究旨在描述3例中国小口病患者的临床特征并鉴定其遗传缺陷。方法:我们对来自3个无血缘关系的中国家庭的3例患者进行了详细的眼科检查。应用靶向下一代测序(Targeted NGS)和拷贝数变异(拷贝数变异)分析筛选致病变异。Sanger测序验证、qPCR和分离分析进一步证实。随后,一种结合遗传和结构生物学的方法被用来推断新变异可能的功能后果。结果:3例患者均表现出典型的Oguchi病临床特征,包括夜盲症、特征性眼底外观(Mizuo-Nakamura现象)、杆状反应减弱、ERG波形阴性。他们的视力和视野正常。遗传分析显示SAG有2个致病变异,GRK1有4个致病变异。患者1被鉴定为含有复合杂合SAG变异体c.874C > T (p.R292*)和外显子2缺失。在患者2中发现复合杂合GRK1变异体c.55C > T (p.R19*)和c.1412delC (p.P471Lfs*52)。在患者3中,复合杂合GRK1变异体c.946C > A (p.R316S)和c.1388T > C (p. L463P)。结论:我们首次报道了2例中国Oguchi患者出现GRK1新致病变异(P471Lfs*52、R316S、L463P)和1例Oguchi患者出现SAG,提示GRK1和SAG都是中国Oguchi患者重要的致病基因。
期刊介绍:
Documenta Ophthalmologica is an official publication of the International Society for Clinical Electrophysiology of Vision. The purpose of the journal is to promote the understanding and application of clinical electrophysiology of vision. Documenta Ophthalmologica will publish reviews, research articles, technical notes, brief reports and case studies which inform the readers about basic and clinical sciences related to visual electrodiagnosis and means to improve diagnosis and clinical management of patients using visual electrophysiology. Studies may involve animals or humans. In either case appropriate care must be taken to follow the Declaration of Helsinki for human subject or appropriate humane standards of animal care (e.g., the ARVO standards on Animal Care and Use).